Scott Bergman, PharmD, BCPS (AQ ID)
Associate Professor, Department of Pharmacy Practice
Southern Illinois University Edwardsville School of Pharmacy
PGY2 Infectious Diseases Pharmacy Resident Director
St. John's Hospital
Phone: 217-545-9148
Email: scbergm@siue.edu
Curriculum Vitae (CV)
Education and Training
- Bachelor of Science - Pharmaceutical Sciences, 2002. South Dakota State University - Brookings, SD
- Doctor of Pharmacy, 2004. South Dakota State University College of Pharmacy – Brookings, SD
- Pharmacy Practice Residency, 2004-05. West Virginia University Hospitals – Morgantown, WV
- Infectious Diseases Specialty Pharmacy Residency, 2005-2006, West Virginia University Hospitals and School of Pharmacy – Morgantown, WV
Awards
- Pharmacy Practice Teacher of the Year for SIUE Class of 2010
- Pharmacy Residency Preceptor of the Year for St. John’s Hospital 2012
- Society of Infectious Diseases Pharmacists Residency Award 2012
- Excellence in Innovation Award from the Illinois Pharmacists Association 2012
- New Practitioner Leadership Award from the Illinois Council of Health-System Pharmacists 2013
Teaching responsibilities
- PHPT 725: Integrated Pharmacotherapeutics – Infectious Diseases
- PHPR 749: Vaccine-Preventable Diseases and Immunization Training
- PHEL 774: Advanced Infectious Diseases Pharmacotherapy
- PHEP 784-786: Advanced Pharmacy Practice Experiences, patient care elective rotation in infectious diseases.
Practice site information
He has been residency program director for the PGY2 Infectious Diseases Pharmacy Residency since 2012. Click here for more information on the residency programs at St. John’s Hospital.
Clinical and Scholarly interests
Representative Publications
Shah PJ. Bergman S, Vegi S, Sundareshan S. Fusarium peritonitis successfully managed with posaconazole and catheter removal. Peritoneal Dialysis International (in-press).
Klepser ME, Hagerman JK, Klepser SA, Bergman SJ, Klepser DG. A community pharmacy-based influenza screening and management program shortens time to treatment versus pharmacy screening with referral to standard of care. Illinois Pharmacist. 2014; 76 (2): 12-18.
Bergman SJ, Shah PJ. Chapter 139. Dermatophytosis: Toeing the Line. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 9th ed. New York: McGraw-Hill; 2014. p. 361-363.
Percival KM, Bergman SJ. Update on posaconazole pharmacokinetics: Comparison of new and old formulations. Current Fungal Infection Reports. 2014; 8: 139-145.
Santanello CD, Dow AC, Bergman SJ. Active Learning Strategies: Student Perceptions. Academic Exchange Quarterly. 2014; 18 (1):24-34.
Bergman SJ, Doss MM, Connor-Hustedde H. Fungal Infections. In: Mason B, Parker D, Lott RS, editors. Capstone Pharmacy Review. Burlington: Jones and Bartlett; 2014. p. 324-343.
Campbell-Petkewicz KA, Bergman SJ, Otsuka ST, Collins-Lucey EH. Immunizations. In: Mason B, Parker D, Lott RS, eds. Capstone Pharmacy Review. Burlington: Jones and Bartlett; 2014. p. 712-720.
Santanello CD, Bergman, SJ. Sarah’s Sickness: The Diagnosis and Treatment of an Infectious Disease. [Case Study] 2014. Buffalo, NY: National Center for Case Study Teaching in Science, University at Buffalo, State University of New York. http://sciencecases.lib.buffalo.edu/cs/collection/detail.asp?case_id=721&id=721
Schmees PM, Bergman SJ, Strader BD, Metzke ME, Pointer S, Valenti KM,. Outcomes Of An Extended-Infusion Piperacillin-Tazobactam Protocol Implementation In A Community Teaching Hospital Adult Intensive Care Unit. Journal of Health-System Pharmacy Residents. 2013; 2 (2): 1-8.
Bergman SJ, Collins-Lucey EH. Update on Human Papillomavirus Vaccines: Life Saver or Controversy Magnet? Clinical Microbiology Newsletter. 2012; 34(11) 85-91.
Bergman SJ, Ferguson M, Santanello C. Interferons as therapeutic agents for infectious diseases. Infectious Disease Clinics of North America. 2011; 25(4): 819-834.
Bergman SJ, Tyagi I, Ronald K. Antifungal dosing in critically ill patients. Current Fungal Infection Reports. 2010; 4(2): 78-86.
Htwe TH, Bergman S, Koirala J. Famcicovir substitution for patients with acyclovir-associated renal toxicity. Journal of Infection, 2008; 57: 266-268.
Bergman SJ, Speil C, Short M, Koirala JK. Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high risk populations. Infectious Disease Clinics of North America. 2007; 21 (3) Sept: 821-846.